Finally, a BLV-infected calf that was inoculated with Boch4G12 showed a proliferation of CD4+ T cells in response to the BLV antigen and a reduction in BLV provirus loads, suggesting that Boch4G12 has therapeutic potential for controlling BLV infection. This evidence concerns the gene CD4 and deltaretrovirus infections.